Ziopharm Oncology to Report Second Quarter Financial Results on August 9, 2021
July 26 2021 - 4:30PM
Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced that
management will host a conference call and webcast on Monday,
August 9, at 4:30 p.m. EDT to provide a corporate update and
discuss financial results for the second quarter ended June 30,
2021.
The conference call can be accessed by dialing
877-451-6152 (U.S. and Canada) or 201-389-0879 (International). The
passcode for the conference call is 13721210. A live webcast may be
accessed using the link here, or by visiting the “Investors”
section of the Ziopharm website at www.ziopharm.com. The call will
be recorded and available for replay on the Company’s website for
approximately 90 days after the call.
About Ziopharm Oncology,
Inc.Ziopharm is developing non-viral and cytokine-driven
cell and gene therapies that weaponize the body’s immune system to
treat the millions of people globally diagnosed with cancer each
year. With its multiplatform approach, Ziopharm is at the forefront
of immuno-oncology. Ziopharm’s pipeline is built for commercially
scalable, cost-effective T-cell receptor T-cell therapies based on
its non-viral Sleeping Beauty gene transfer platform, a precisely
controlled IL-12 gene therapy, and rapidly manufactured Sleeping
Beauty-enabled CD19-specific CAR-T program. The Company has
clinical and strategic collaborations with the National Cancer
Institute, The University of Texas MD Anderson Cancer Center and
Regeneron Pharmaceuticals. For more information, please visit
www.ziopharm.com.
Investor Relations Contact:Adam
D. Levy, Ph.D., MBAEVP, Corporate Development and Investor
RelationsT: 508.552.9255E: alevy@ziopharm.com
ZIOPHARM Oncology (NASDAQ:ZIOP)
Historical Stock Chart
From Mar 2024 to Apr 2024
ZIOPHARM Oncology (NASDAQ:ZIOP)
Historical Stock Chart
From Apr 2023 to Apr 2024